TAIDE (Trustworthy AI Dialog Engine)
Taiwan's national trustworthy Traditional-Chinese LLM program; open-sourced the commercially usable TAIDE-LX-7B in April 2024, with healthcare as a priority deployment domain.
Taiwan's 2024-2026 push into generative-AI medicine, precision genomics, medical-grade wearables, remote monitoring, digital therapeutics and smart eldercare.
45 result(s)
Taiwan's national trustworthy Traditional-Chinese LLM program; open-sourced the commercially usable TAIDE-LX-7B in April 2024, with healthcare as a priority deployment domain.
Billed as the world's first Chinese-language generative voice medical-record system; clinicians dictate and the AI engine rapidly drafts records and treatment suggestions.
Microsoft set up a dedicated Taiwan healthcare team in 2021, combining Azure OpenAI (ChatGPT-class) with clinical nursing expertise to drive generative-AI transformation.
Co-founded by Yu-Chuan (Jack) Li; trains AI on a very large prescription corpus for medication-safety guardrails (MedGuard) and diagnostic/charting support (DxPrime), with international traction.
Uses generative and agentic AI to support clinical operations, integrating TAIDE into its Co-Healer system; one of the MOHW/TFDA-designated clinical-AI validation centers.
Built its own TVGH Brain LLM and TVGH Cloud No.1 supercomputer for AI nursing records and precision-medicine compute; designated an MOHW AI-center lead hospital.
Co-built an AI inference cloud with ASUS, integrating HIS and compute for imaging interpretation and ECG support, and adopting generative AI for training and clinical use.
TVGH partnered with NVIDIA and SAS on a visual data-mining AutoML system, deploying edge computing to speed AI such as intradialytic risk prediction.
The MOHW designed an EMR auto-coding assist system to advance documentation standardization, winning a Future Tech Award, amid legal/standardization debates on generative-AI records.
Academia Sinica-led large-scale genome x EMR program; over 560,000 participants forming the world's largest Han-Chinese precision-medicine cohort, with Nature publications in 2025.
Taiwan's largest biobank with 200,000+ volunteers, integrating physicals, biochemistry, questionnaires, genomic and imaging data; over 1.5 PB.
Asia's cancer-genomics leader; ACTOnco was the first Asia-based FDA-cleared comprehensive genomic profiling test for all solid tumors. Delta announced acquisition of a 90%+ stake in 2025.
Genetic-testing firm centered on maternal-fetal medicine and cancer precision medicine, offering 10+ NGS tests with multiple LDT certifications.
A Healthbanks-group company (formerly CreSource/GGA) focused on precision-health genomics and digital health; serves about half of Taiwan's newborns.
One of Taiwan's largest commercial genome-sequencing firms, spanning research sequencing, clinical testing and nucleic-acid/peptide CDMO; building an APAC sequencing hub.
Pharmacogenomics-focused firm helping avoid severe drug allergies (SJS/TEN), aligned with NHI-covered pre-prescription HLA screening.
Genetic-testing company centered on prenatal fetal testing and preventive medicine; partnered with Vita Genomics and BGI to bring NGS-based NIPT.
Taiwan's leading digital-pathology and medical-imaging AI firm; Quanta-backed, listed on the Emerging Board in 2024, with whole-slide pathology, bone-marrow smear and colonoscopy polyp products.
From May 1, 2024, NHI reimburses cancer NGS across 19 cancer types, benefiting ~20,000+ patients per year.
The Lai administration's flagship Healthy Taiwan vision advances precision and smart-tech medicine; the deep-cultivation plan (2025-2029) carries a NT$48.9B budget.
The government designates precision health a strategic industry within the five trusted industries, with the NSTC fostering cross-disciplinary talent and industrialization.
One of the world's most compact 12-lead ECG systems, using patented snap-on electrodes to cut acquisition time and reduce lead-misplacement errors; usable both at home and in clinical settings.
A Hsinchu startup offering medical-grade personal health-record devices that continuously capture ECG, respiration, skin temperature and posture, with AI algorithms analysing the ECG signal.
A pure-SaaS AI cloud platform for ECG interpretation that is compatible with multiple ECG devices, including Apple Watch and 24-hour Holter monitors.
Health watches/bands integrating a pair of medical-grade ECG and PPG sensors with ASUS HealthAI, focused on blood pressure, SpO2, heart rate, sleep and mood monitoring.
Provides 24/7 continuous health monitoring (optical HR, HRV, Pulse Ox SpO2, advanced sleep, Body Battery) and opens its data for clinical research collaborations.
Consumer-grade single-lead ECG and irregular-rhythm notifications, enabled in Taiwan after TFDA approval, detecting atrial fibrillation only.
Uses a standard RGB camera to scan the face and, via remote photoplethysmography (rPPG) + AI, measures HR, blood pressure, SpO2, respiration and HRV in ~50 seconds, contact-free.
A Taiwan-made continuous glucose monitoring (CGM) system updating readings every minute, with a rechargeable, reusable transmitter (5-year warranty) aimed at cutting consumable waste.
Since 2017 Taiwan has conditionally reimbursed CGM for eligible Type-1 diabetes patients; in 2025 the MOHW pledged to review loosening eligibility and access channels by year-end.
Taiwan's first TFDA-licensed digital therapeutic - insulin-dose-titration software helping diabetes patients adjust insulin doses safely.
A large Asian chronic-disease AI platform connecting glucose and other measurements with education, providers and insurers, expanding overseas (notably Japan) via DTx and pay-for-performance models.
Quanta's family of AI medical-cloud platforms - AI Medical Cloud (aim), health care (apc) and home telecare (home) - linking vital-sign monitoring with analytics.
A single-lead-ECG + AI home sleep-apnea test using one lightweight device for up to 7 nights at home, with app upload to a cloud platform that generates the report.
A sleep-apnea therapy device that uses oral negative pressure to keep the tongue from falling back and maintain an open upper airway, marketed as comfortable, quiet and portable.
Builds smart-hospital infrastructure on the WISE-PaaS cloud and edge computing, integrating in-hospital information and physiological-data collection and analytics.
Combines AI with medical equipment to monitor patient status and vital signs in real time in the ICU, helping ICU staff judge when to intervene.
An ICU AI critical-care early-warning system that flags patient deterioration so staff can intervene early and supports clinical decision-making.
A pilot where medical teams deliver near-hospital-level treatment at patients' homes, reimbursed via a bundled daily fee that includes an IoT vital-sign-monitoring fee - seen as the bellwether for RPM reimbursement.
An NHI plan encouraging medical cooperation in mountain and outlying-island areas, reimbursing video specialist consultations across ophthalmology, ENT, dermatology, cardiology, neurology, GI and emergency care.
A fibre-optic-sensing smart mattress that predicts bed-exit ~90 seconds in advance and continuously monitors respiration, heartbeat, bed-exit and activity.
60GHz millimetre-wave radar detects heartbeat, respiration and falls regardless of light or weather, commonly used in hospitals, care facilities and home long-term care.
Digital cognitive behavioural therapy for insomnia (CBT-I); Taiwan clinically favours CBT-I as first-line non-drug therapy, making digitalisation a potential DTx entry point.
The TFDA has brought SaMD under the Medical Devices Act, set up a Smart Medical Device Office, and published AI/ML SaMD registration guidance and a list of cleared devices.
A health-management organisation driving preventive medicine with big data, having accumulated a large health-examination dataset and extending toward digital health and personalised management.